Research-informed education, independent testing, and practical guidance across the evolving science and application of molecular hydrogen.
Explore H2HUBB articles covering molecular hydrogen research, hydrogen water, hydrogen inhalation, dosing, product testing, safety, technology, and practical education for consumers and the hydrogen industry.
In 12 patients with confirmed SARS-CoV-2 infection, every patient showed clinical improvement and excellent tolerance to H₂ therapy. These findings add human evidence that helps define the outcomes that did and did not change with molecular hydrogen in this study.
Read ArticleIn 4 patients, erythema of these 4 patients and associated symptoms improved significantly after the H₂ treatment and did not recur. These findings add human evidence supporting molecular…
Read ArticleIn 20 patients with advanced non-small cell lung cancer, 45 the researchers found that the prevalence of insomnia, dizziness and headache could be reduced significantly after H₂ inhalation,…
Read ArticleIn 4 patients with hyperuricemia, following an 8-week period, the High-HRW group exhibited a significant reduction in blood uric acid levels compared to the baseline (488.2 ± 54.1…
Read ArticleIn 8 healthy participants, sEROLOGICAL TESTING: A predefined battery of laboratory testing was analyzed prior to and within 2 hours following the completion of H₂ exposure. These findings…
Read ArticleThis human publication evaluated hydrogen gas in 2014 patients with out-of-hospital cardiac arrest achieved spontaneous return of circulation. This pilot study suggests therapeutic potential, while larger randomized, placebo-controlled…
Read ArticleIn 50 patients with acute cerebral infarction, the H₂ group showed no significant adverse effects with improvements in oxygen saturation. These findings add human evidence that helps define…
Read ArticleIn 80 patients with locally advanced head and neck cancer (LAHNC), all patients received 33 fractions of H₂ gas inhalation on the same day as the IMRT. These…
Read ArticleHydrogen inhalation was associated with greater reductions in systolic and diastolic blood pressure than control treatment through 24 weeks.
Read ArticleIn 2 patients, compared to the control group, participants in HI group maintained greater improvement in the level of HbA1c (-0.94% vs -0.46%), FPG (-22.7 mg/dL vs -11.7…
Read ArticleIn 431 patients with type 2 diabetes mellitus (T2DM), higher baseline HbA1c level and shorter diabetes duration is related to greater clinical response to HI. These findings add…
Read ArticleIn 60 participants with hypertension aged 50-70 years, when stratified by age (aged 50-59 years versus aged 60-70 years), participants in the older H₂-O₂ group showed a larger…
Read ArticleIn 2025 participants with mean body mass index (BMI) ≥ 25 kg/m², HRW significantly reduced total cholesterol (TC) (WMD: − 6.71 mg/dL; 95% CI: − 10.38 to −…
Read ArticleThe results showed a slight decrease in ALT, AST, and ALP levels in the treated group with HRW compared to the PW group. These findings add human evidence…
Read ArticleIn participants, interestingly, the hydrogen-rich water group had a higher volume of water intake as compared to the control group, with regular water consumption (81.8 ± 5.1 mL/day…
Read Article